>
Case Studies
Filtered by Service Areas
Filtered by Therapeutic Areas
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Therapeutic Area
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Therapeutic Area
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Therapeutic Area
Applied advanced analysis to understand manufacturing variance for cell therapy firm
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Operation Strategy (CMC)
Therapeutic Area
Cell therapy
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Therapeutic Area
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Therapeutic Area
What can portfolio management do for molecule teams?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management (Molecule Teams)
Therapeutic Area
N/A
What can portfolio management do for early commercialization?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management (Early Commercialization)
Therapeutic Area
N/A
What can portfolio management do for governance?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management (Governance)
Therapeutic Area
N/A
Website assessment for early stage biopharmaceutical company
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Qualitative)
Therapeutic Area
Central Nervous System (Alzheimer's, Lysosomal Storage Disorders)
Market research for novel cell transplant procedure
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Qualitative)
Therapeutic Area
Oncology (ASCT)
Support services optimization for orphan specialty product portfolio
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research
Therapeutic Area
Gene Therapy & Orphan Disease (Orphan)
Demand modeling and scenario planning for a novel, mass-market agent for hypercholesterolemia
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Demand Modelling, Scenario Planning)
Therapeutic Area
Other Therapeutic Areas (Cardiovascular)
Positioning for a novel, ultra-orphan specialty drug: KOL and payer deep dive
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (KOL, Payor, Benchmarking)
Therapeutic Area
Gene Therapy & Orphan Disease (Orphan)
What is the market potential for a novel formulation for treating Diabetic Foot Ulcers?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Market Forecast, TPP Development)
Therapeutic Area
Other Therapeutic Areas (Diabetic Foot Ulcer)
How to forecast R&D costs and allocate resources appropriately for a rare disease company?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management (Activity-Based Costing)
Therapeutic Area
Gene Therapy & Orphan Drugs (Orphan)
Process overhaul at a Top 5 pharma
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management
Therapeutic Area
N/A
What is the go-to-market strategy in the U.S. for an Asia-based medical device startup company?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Go-to-market Strategy, Valuation, Investment Deck Preparation)
Therapeutic Area
Other Therapeutic Areas (Medical Devices)
Analytical model to understand IP-driven commercial risks to an oncology portfolio
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Modeling, Intellectual Property)
Therapeutic Area
Oncology (Immuno-oncology)
Determine the better investment (in-house vs in-license) option for a small molecule drug
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Valuation, Business Development)
Therapeutic Area
Central Nervous System (Parkinson's, ALS)
Develop a strategic outlook for an infectious disease (ID) area and define organizational framework
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (TPP Development, Disease Area Strategy)
Therapeutic Area
Other Therapeutic Areas (Infectious Disease)
Platform technology technical evaluation and deal trends
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Technical Assessment)
Therapeutic Area
Other Therapeutic Areas (CAR-T, CRISPR), Gene Therapy
Strategic competitive intelligence assessments
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Competitive Insights)
Therapeutic Area
Central Nervous System (Alzheimer's, Parkinson's, ALS)
Immuno-oncology competitive intelligence
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Competitive assessment)
Therapeutic Area
Oncology (Solid Tumor, Immuno-oncology)
Technology prioritization for stem cell (iPSC) regenerative medicine technology
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Technical Assessment)
Therapeutic Area
Oncology (Stem Cell)
Landscape assessment, development opportunities, and forecasting for novel prostate cancer molecule
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Market Forecast, Competitive Assessment)
Therapeutic Area
Oncology (Solid Tumor, Prostate)
Market forecast and technology valuation for a novel immuno-oncology cell therapy
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Valuation and Market Forecast)
Therapeutic Area
Oncology (Cell Therapy, Hematology)
Detailed global sales forecast and NPV model in Ulcerative Colitis and Crohn’s Disease
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Valuation)
Therapeutic Area
Auto-immune (UC and Crohn's)
Indication prioritization for platform technology
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Assessment)
Therapeutic Area
Central Nervous System (Alzheimer's)
How to prioritize indications for an early stage company with a disruptive technology?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Prioritization)
Therapeutic Area
Central Nervous System
Portfolio planning and management
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Prioritization)
Therapeutic Area
Gene Therapy & Orphan Disease
Company Strategy Alignment
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Corporate Strategy)
Therapeutic Area
Infectious Disease
Indication evaluation and prioritization for development stage pharmaceutical client
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Prioritization)
Therapeutic Area
Gene Therapy & Orphan Disease
How to prioritize indications for an early stage company with a disruptive technology?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Prioritization)
Therapeutic Area
Gene Therapy & Orphan Disease
On-demand, Short-term Ops Support for a Pre-IND Biotech
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Operation Strategy (CMC)
Therapeutic Area
Oncology, Other Therapeutic Areas
Assess the biosimilars market and create a medical affairs strategy to prepare for biosimilar launches
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Operation Strategy (medical affairs)
Therapeutic Area
Oncology (immunoncology)
Launch messaging and positioning for a specialty product
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (launch messaging and positioning)
Therapeutic Area
Gene Therapy & Orphan Disease
Market research for novel oncology drug with NGS vs. IHC diagnostic strategy
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Quantitative and Qualitative Study)
Therapeutic Area
Oncology (diagnostics, NGS, Solid Tumor)
US quantitative market assessment: novel therapy for infectious disease
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Market Research (Quantitive & Qualitative Study, TPP testing, Market Forecast Research)
Therapeutic Area
Other Therapeutic Areas (Infectious Disease, Tuberculosis)
Analytics overhaul at a top 10 pharma
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Portfolio Management
Therapeutic Area
N/A
Pre-clinical Stage, Cutting Edge Biotech in Need of Strategy and Analysis Leverage
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy
Therapeutic Area
Central Nervous System
What is the product positioning strategy for two novel early stage IO candidates for global pharma company?
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy, Portfolio Management (Disease Area Strategy)
Therapeutic Area
Oncology (Solid Tumor), Auto-immune
Quantitative market assessment of preselected diseases and selection of potential new indications
I'm a paragraph. Click here to add your own text and edit me. It's easy.
Services Area
Commercial Strategy (Indication Prioritization), Portfolio Management
Therapeutic Area
Gene Therapy & Orphan Disease